New therapeutic strategies in acute lymphoblastic leukemia
/in Acute Leukemia, International PublicationsDendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
/in Acute Leukemia, International PublicationsRecent advances in cancer immunotherapy with an emphasis on vaccines
/in Colorectal Cancer, International PublicationsRandomized clinical studies of anti-tumor vaccination: state of the art in 2008
/in Dendritic Cells, International Publications, IOZK VeröffentlichungenTumour vaccine approaches for CNS malignancies: progress to date
/in Dendritic Cells, Glioblastoma, International PublicationsA phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsOncothermia treatment of cancer: from the laboratory to clinic
/in Hyperthermia, International PublicationsAutologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro
/in Breast Cancer, Dendritic Cells, International PublicationsNewcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer